Status:
COMPLETED
A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This 2 arm study will compare the effect on hemoglobin response of Mircera and epoetin beta, in patients with chronic renal anemia who are on dialysis. Eligible patients will be randomized to receive ...
Eligibility Criteria
Inclusion
- adult patients, \>=18 years of age;
- chronic renal anemia requiring dialysis;
- maintenance hemodialysis or peritoneal dialysis for \>=2 weeks before and during screening;
- adequate iron status.
Exclusion
- previous epoetin treatment within 8 weeks prior to screening;
- failing renal graft in place;
- bleeding episode necessitating transfusion within 8 weeks prior to screening;
- poorly controlled hypertension;
- previous treatment with Mircera.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
265 Patients enrolled
Trial Details
Trial ID
NCT00442793
Start Date
May 1 2007
End Date
May 1 2010
Last Update
November 2 2016
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing, China, 100050
2
Beijing, China, 10029
3
Beijing, China, 100853
4
Chengdu, China, 610072